Advertisement
Canada markets closed
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7283
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    79.21
    +0.22 (+0.28%)
     
  • Bitcoin CAD

    84,423.04
    -1,446.55 (-1.68%)
     
  • CMC Crypto 200

    1,309.62
    +14.95 (+1.15%)
     
  • GOLD FUTURES

    2,316.70
    -5.60 (-0.24%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,160.00
    -26.50 (-0.15%)
     
  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • NIKKEI 225

    38,349.79
    +147.42 (+0.39%)
     
  • CAD/EUR

    0.6775
    -0.0001 (-0.01%)
     

Should Income Investors Buy This Soon-to-Be Dividend King?

Should Income Investors Buy This Soon-to-Be Dividend King?

Imagine spending a lifetime building your investment portfolio only to worry about whether you will outlive the balance in your investment accounts. If you are exclusively buying growth stocks with the intent of eventually selling them off for capital gains to sustain your lifestyle, running out of money could be a possibility. Consider medical device maker Medtronic (NYSE: MDT).